129 related articles for article (PubMed ID: 24837088)
1. Drug promotion tactics-yet another pharma deception?
Tagore A
Int J Clin Pract; 2014 Jun; 68(6):662-5. PubMed ID: 24837088
[TBL] [Abstract][Full Text] [Related]
2. Clarifying the costs of conflicts of interest.
Mayes C; Lipworth W; Kerridge I
Int J Clin Pract; 2015 Mar; 69(3):384-5. PubMed ID: 25727803
[No Abstract] [Full Text] [Related]
3. Response to clarifying the costs of conflicts of interest.
Stossel TP; Barton DW; Stell LK
Int J Clin Pract; 2015 Mar; 69(3):385-6. PubMed ID: 25727804
[No Abstract] [Full Text] [Related]
4. Pharmaism: a tale of two perspectives.
Citrome L; Karagianis J; Maguire GA; Nierenberg AA
Int J Clin Pract; 2014 Jun; 68(6):659-61. PubMed ID: 24837087
[No Abstract] [Full Text] [Related]
5. After 20 years, industry critics bury skeptics, despite empirical vacuum.
Barton D; Stossel T; Stell L
Int J Clin Pract; 2014 Jun; 68(6):666-73. PubMed ID: 24837089
[TBL] [Abstract][Full Text] [Related]
6. [Conflicts of interest in the medical profession].
Altisent R; Delgado-Marroquín MT; Astier-Peña MP
Aten Primaria; 2019 Oct; 51(8):506-511. PubMed ID: 31248656
[TBL] [Abstract][Full Text] [Related]
7. [Conflicts of interest, an insidious blight on medicine].
Altisent R
Aten Primaria; 2019 Oct; 51(8):469-470. PubMed ID: 31202475
[No Abstract] [Full Text] [Related]
8. Physician Exposure to Direct-to-Consumer Pharmaceutical Marketing: Potential for Creating Prescribing Bias.
Brown JL
Am J Med; 2017 Jun; 130(6):e247-e248. PubMed ID: 28089801
[No Abstract] [Full Text] [Related]
9. No more free lunches.
Abbasi K; Smith R
BMJ; 2003 May; 326(7400):1155-6. PubMed ID: 12775587
[No Abstract] [Full Text] [Related]
10. Pharmaceutical companies and medical practitioners or "the beast and the beauty"?
Villalba L
Clin Dermatol; 2019; 37(1):16-20. PubMed ID: 30554617
[TBL] [Abstract][Full Text] [Related]
11. Doctors behaving badly?
Tattersall MH; Kerridge IH
Med J Aust; 2006 Sep; 185(6):299-300. PubMed ID: 16999666
[No Abstract] [Full Text] [Related]
12. Defensive medicine: Sword of Damocles.
Dudeja S; Dhirar N
Natl Med J India; 2018; 31(6):364-365. PubMed ID: 31397373
[TBL] [Abstract][Full Text] [Related]
13. Mixing Dinner and Drugs-Is It Ethically Contraindicated?
Essi DF
AMA J Ethics; 2015 Aug; 17(8):787-95. PubMed ID: 26270881
[No Abstract] [Full Text] [Related]
14. Whose practice is this anyway? To conform or not to conform.
Awan S; Grant-Kels JM; Graff J
J Am Acad Dermatol; 2016 Dec; 75(6):1271-1273. PubMed ID: 27846958
[No Abstract] [Full Text] [Related]
15. Psychiatrists' relationships with pharmaceutical companies: part of the problem or part of the solution?
Insel TR
JAMA; 2010 Mar; 303(12):1192-3. PubMed ID: 20332407
[No Abstract] [Full Text] [Related]
16. Financial incentives and the prescription of newer vaccines by doctors in India.
Lodha R; Bhargava A
Indian J Med Ethics; 2010; 7(1):28-30. PubMed ID: 20166294
[No Abstract] [Full Text] [Related]
17. Take this medicine: the legality of prescription incentive schemes.
Fanning J; Glover-Thomas N
Med Law Rev; 2010; 18(3):417-26. PubMed ID: 20739438
[No Abstract] [Full Text] [Related]
18. Should physicians rely on pharmaceutical detailing for their education?
van Schalkwyk JM; Turner MJ
J Clin Hypertens (Greenwich); 2013 Mar; 15(3):218. PubMed ID: 23458597
[No Abstract] [Full Text] [Related]
19. Double standards in clinical practice ethics.
Harris IA; Naylor JM
Med J Aust; 2014 Feb; 200(2):76. PubMed ID: 24484092
[No Abstract] [Full Text] [Related]
20. Industry relationships with physicians under scrutiny.
Beller GA
J Nucl Cardiol; 2008; 15(6):737-8. PubMed ID: 18984446
[No Abstract] [Full Text] [Related]
[Next] [New Search]
